Cipher Pharmaceuticals Inc (CPHRF)
6.30
-0.07
(-1.10%)
USD |
OTCM |
May 20, 12:15
Cipher Pharmaceuticals Shareholders Equity (Quarterly): 85.59M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 85.59M |
December 31, 2023 | 80.52M |
September 30, 2023 | 77.55M |
June 30, 2023 | 70.20M |
March 31, 2023 | 67.14M |
December 31, 2022 | 64.08M |
September 30, 2022 | 44.45M |
June 30, 2022 | 41.92M |
March 31, 2022 | 40.35M |
December 31, 2021 | 38.90M |
September 30, 2021 | 36.85M |
June 30, 2021 | 36.36M |
March 31, 2021 | 33.93M |
December 31, 2020 | 32.64M |
September 30, 2020 | 32.80M |
June 30, 2020 | 31.17M |
March 31, 2020 | 30.71M |
December 31, 2019 | 28.01M |
September 30, 2019 | 24.86M |
June 30, 2019 | 27.09M |
March 31, 2019 | 25.64M |
December 31, 2018 | 24.76M |
September 30, 2018 | 25.62M |
June 30, 2018 | 24.68M |
March 31, 2018 | 22.28M |
Date | Value |
---|---|
December 31, 2017 | 23.30M |
September 30, 2017 | 19.04M |
June 30, 2017 | 16.09M |
March 31, 2017 | 15.20M |
December 31, 2016 | 18.50M |
September 30, 2016 | 29.39M |
June 30, 2016 | 50.09M |
March 31, 2016 | 52.56M |
December 31, 2015 | 54.26M |
September 30, 2015 | 51.60M |
June 30, 2015 | 52.92M |
March 31, 2015 | 52.82M |
December 31, 2014 | 54.05M |
September 30, 2014 | 52.41M |
June 30, 2014 | 45.68M |
March 31, 2014 | 39.03M |
December 31, 2013 | 36.40M |
September 30, 2013 | 20.26M |
June 30, 2013 | 16.41M |
March 31, 2013 | 13.77M |
December 31, 2012 | 12.47M |
September 30, 2012 | 11.03M |
June 30, 2012 | 9.841M |
March 31, 2012 | 9.735M |
December 31, 2011 | 9.305M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
24.86M
Minimum
Sep 2019
85.59M
Maximum
Mar 2024
46.26M
Average
37.87M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 92.55M |
Total Liabilities (Quarterly) | 6.958M |
Current Ratio | 7.964 |